Literature DB >> 9124857

Antimicrobial susceptibility patterns of some recently established coryneform bacteria.

G Funke1, V Pünter, A von Graevenitz.   

Abstract

The susceptibility patterns of 480 isolates representing six recently defined species of coryneform bacteria (Corynebacterium amycolatum [n = 101], Corynebacterium auris [n = 48], Corynebacterium glucuronolyticum [n = 86], Brevibacterium casei [n = 50], Dermabacter hominis [n = 49], and Turicella otitidis [n = 146]) to 17 antimicrobial agents were determined by an agar dilution method. Most significantly, for C. amycolatum strains the MICs at which 90% of isolates are inhibited were > or = 32 micrograms/ml for nearly all agents. However, all 480 strains examined were susceptible to glycopeptide antibiotics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9124857      PMCID: PMC163638     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

Review 1.  Coryneform bacteria in infectious diseases: clinical and laboratory aspects.

Authors:  M B Coyle; B A Lipsky
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

2.  Most Corynebacterium xerosis strains identified in the routine clinical laboratory correspond to Corynebacterium amycolatum.

Authors:  G Funke; P A Lawson; K A Bernard; M D Collins
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

3.  Mediastinitis due to multiple resistant Corynebacterium xerosis.

Authors:  O Lortholary; A Buu-Hoï; J Y Fagon; J Pierre; M Slama; L Gutmann; J F Acar
Journal:  Clin Infect Dis       Date:  1993-01       Impact factor: 9.079

4.  Characterization of Brevibacterium spp. from clinical specimens.

Authors:  E Gruner; G E Pfyffer; A von Graevenitz
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

5.  Interpretive criteria and quality control parameters for determining bacterial susceptibility to fosfomycin tromethamine.

Authors:  A L Barry; M A Pfaller; P C Fuchs; F C Tenover; L B Reller; S D Allen; D J Hardy; E H Gerlach
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

6.  Isolation of Corynebacterium group JK from clinical specimens with a semiselective medium.

Authors:  S Wichmann; C H Wirsing von Koenig; E Becker-Boost; H Finger
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

7.  Three cases of opportunistic infection caused by propionic acid producing Corynebacterium minutissimum.

Authors:  B Van Bosterhaut; R Cuvelier; E Serruys; F Pouthier; G Wauters
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

8.  Bacteremia caused by Brevibacterium species in an immunocompromised patient.

Authors:  S S Kaukoranta-Tolvanen; A Sivonen; A A Kostiala; P Hormila; M Vaara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

9.  Comparative chemotaxonomic studies of mycolic acid-free coryneform bacteria of human origin.

Authors:  C Barreau; F Bimet; M Kiredjian; N Rouillon; C Bizet
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

10.  Characterization of antibiotic-resistant Corynebacterium striatum strains.

Authors:  M C Roberts; R B Leonard; A Briselden; F D Schoenknecht; M B Coyle
Journal:  J Antimicrob Chemother       Date:  1992-10       Impact factor: 5.790

View more
  33 in total

Review 1.  Need for susceptibility testing guidelines for fastidious or less-frequently isolated bacteria.

Authors:  James H Jorgensen
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Relapsing Brevibacterium casei peritonitis: value of 16S rRNA gene sequencing in accurate species identification.

Authors:  Koen Poesen; Gert Meeus; Michaël Boudewijns; Johan Colaert; Peter Doubel
Journal:  Perit Dial Int       Date:  2012 May-Jun       Impact factor: 1.756

3.  Minimal inhibitory concentrations of linezolid against clinical isolates of coryneform bacteria.

Authors:  G Funke; C Nietznik
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-09       Impact factor: 3.267

Review 4.  Turicella otitidis and Corynebacterium auris: 20 years on.

Authors:  A von Graevenitz; G Funke
Journal:  Infection       Date:  2013-06-18       Impact factor: 3.553

5.  A rare and under-recognized pathogen in peritoneal dialysis peritonitis: Corynebacterium jeikeium.

Authors:  C T Chao; J W Huang; C J Yen
Journal:  Perit Dial Int       Date:  2013 Sep-Oct       Impact factor: 1.756

6.  Evaluation of the RapID CB Plus system for identification of Corynebacterium species and other gram-positive rods.

Authors:  M K Hudspeth; S Hunt Gerardo; D M Citron; E J Goldstein
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

7.  Characteristics of Arthrobacter cumminsii, the most frequently encountered Arthrobacter species in human clinical specimens.

Authors:  G Funke; M Pagano-Niederer; B Sjödén; E Falsen
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  [Description of 8 cases with gonadal dysgenesis syndrome type 46XY].

Authors:  E Deligeoroglou; P Fotaki; D Kokkalis; G Creatsas
Journal:  Akush Ginekol (Sofiia)       Date:  2001

9.  In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against Coryneform bacteria.

Authors:  L Martínez-Martínez; A Pascual; A I Suárez; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  Comprehensive study of Corynebacterium freneyi strains and extended and emended description of Corynebacterium freneyi Renaud, Aubel, Riegel, Meugnier, and Bollet 2001.

Authors:  Guido Funke; Reinhard Frodl
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.